FFND vs. PJP ETF Comparison

Comparison of The Future Fund Active ETF (FFND) to PowerShares Dynamic Pharmaceuticals (PJP)
FFND

The Future Fund Active ETF

FFND Description

Northern Lights Fund Trust II - The Future Fund Active ETF is an exchange traded fund launched by Northern Lights Fund Trust II. The fund is managed by The Future Fund, LLC. It invests in public equity markets of the United States. The fund invests directly, through derivatives and through other funds in stocks of companies operating across diversified sectors. It employs long/short strategy and uses derivatives such as futures and options to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It employs proprietary research to create its portfolio. Northern Lights Fund Trust II - The Future Fund Active ETF was formed on August 24, 2021 and is domiciled in the United States. The investment seeks to provide capital appreciation. Under normal market conditions, the fund, which is an actively managed ETF, will primarily invest in the equity securities of companies that the adviser believes to be best positioned to take advantage of or profit from emerging technological or social trends or developments.

Grade (RS Rating)

Last Trade

$22.52

Average Daily Volume

2,475

Number of Holdings *

36

* may have additional holdings in another (foreign) market
PJP

PowerShares Dynamic Pharmaceuticals

PJP Description The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$80.46

Average Daily Volume

23,875

Number of Holdings *

22

* may have additional holdings in another (foreign) market
Performance
Period FFND PJP
30 Days -0.71% 2.79%
60 Days 1.09% 2.94%
90 Days 4.85% 4.96%
12 Months 34.90% 6.37%
1 Overlapping Holdings
Symbol Grade Weight in FFND Weight in PJP Overlap
LLY C 4.66% 5.77% 4.66%
FFND Overweight 35 Positions Relative to PJP
Symbol Grade Weight
GOOGL B 9.45%
NVDA B 5.45%
GTLS B 3.98%
CMG A 3.83%
ASML D 3.57%
UBER D 3.46%
ABNB D 3.41%
HALO B 3.37%
CELH C 3.24%
CRM D 3.23%
NFLX C 3.1%
TSLA D 2.93%
KTOS B 2.84%
GPRE F 2.77%
DASH D 2.7%
LPLA C 2.68%
LULU F 2.59%
SCHW A 2.45%
WOLF F 2.3%
ONON D 2.22%
ZTS D 2.13%
FTI A 2.04%
GTLB F 2.03%
VRTX C 1.89%
EW D 1.76%
PANW C 1.65%
AMD D 1.61%
MU B 1.47%
CIEN D 1.46%
MCHP C 1.45%
RIVN F 1.4%
BIDU C 1.3%
PWR A 1.14%
EXAS F 1.09%
YNDX C 0.92%
FFND Underweight 21 Positions Relative to PJP
Symbol Grade Weight
GERN C -7.79%
MRK B -6.04%
AMGN B -5.77%
REGN C -5.57%
PFE C -5.5%
JNJ F -5.5%
ABBV D -5.44%
ABT F -5.44%
ANIP D -4.12%
UTHR A -4.08%
SUPN D -4.0%
PBH D -3.83%
CORT C -3.8%
PRGO D -3.73%
BIIB C -3.61%
INVA C -3.61%
LGND C -3.57%
GILD F -3.36%
JAZZ F -3.23%
PCRX D -3.2%
AMPH F -2.94%
Compare ETFs